Takeda Pharmaceutical Co Ltd (TSE:4502)
円 4205 103 (2.51%) Market Cap: 6.60 Til Enterprise Value: 10.97 Til PE Ratio: 46.05 PB Ratio: 0.90 GF Score: 76/100

Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 12:00AM GMT
Release Date Price: 円4399 (-0.20%)
Naomi Kumagai
JP Morgan Chase & Co, Research Division - Senior Analyst

Good afternoon, everyone. Welcome to the conference. My name is Naomi Kumagai, Japan Pharma Analyst, JPMorgan. It's my great pleasure to introduce Christophe Weber, President and CEO of Takeda. After his presentation, we're going to have a Q&A session at Borgia, across the hallway. With that, I'm going to pass it to Christophe.

Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director

Thank you. Thank you, and good afternoon. I hope you are still awake. It's a long day for everyone. What I can share with you today is that I am coming quite rare. But I'm coming to the JPMorgan conference with a big smile on my face because of what we have achieved at Takeda, and we are very proud of that. So this is what I want to share with you today. What is Takeda today? How we have been transforming the company over the years? At the same time, 12 months ago, during that week, we were closing the acquisition of Shire. We were celebrating our listing on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot